Synta Pharmaceuticals (JOBS) Suspends Elesclomol SYMMETRYSM Trial in Metastatic Melanoma 2/27/2009
More...
|
Marshall Edwards, Inc. (NVGN) Files IND Application for Triphendiol 12/1/2008
More...
|
NewBridge Pharmaceuticals Announces Exclusive Licensing of Clasteon and Gliconorm for Middle East, Africa, Turkey and Caspian Regions 11/25/2008
More...
|
Researchers Identify Mechanism Used By Gene To Promote Metastasis In Human Cancer Cells, Virginia Commonwealth University And VCU Massey Cancer Center Study 9/30/2008
More...
|
A Breakthrough In Contrast-Enhanced Intraoperative Ultrasonography, Asahi-Chuo General Hospital Study 9/19/2008
More...
|
A Potential Metastatic Disease Target Discovered in Cornell University Study 7/21/2008
More...
|
Merck & Co., Inc. (MRK) Release: Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases 6/30/2008
More...
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) Initiates Trofex™ Phase 1 Trial for the Detection and Staging of Metastatic Prostate Cancer 6/12/2008
More...
|
Androgen Production Continues in Prostate Cancer Tumors, Fred Hutchinson Cancer Research Center Study Finds 6/4/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Hospital & Health Network Cancer Center 6/3/2008
More...
|
EntreMed, Inc. (ENMD) Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting; Antitumor Activity Demonstrated in Metastatic Breast Cancer Patients 6/3/2008
More...
|
IDM Pharma, Inc. (IDMI) Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) - Data Presented at the 44th American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Positive Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Barbara Ann Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients 6/2/2008
More...
|
TransMolecular, Inc. Initiates Phase 1 Clinical Trial for Unlabeled TM601 in Recurrent Malignant Glioma 5/30/2008
More...
|
New Cancer Stem Cell Driving Metastatic Tumors Identified In Cornell University's Weill Medical College Study 5/28/2008
More...
|
First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Research 4/21/2008
More...
|
Report Describes First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Study 4/18/2008
More...
|
ArthroCare Corporation (ARTC) Unveils New Direction In Treatment Of Metastatic Lesions 4/7/2008
More...
|
How Does Fu-Zheng-Jie-Du-Decoction Act On Pten Expression In Hepatocellular Carcinoma? 1/16/2008
More...
|
Cold Spring Harbor Laboratory Scientists Identify Cells That Promote Formation of Lethal Lung Metastases 1/15/2008
More...
|
Advanced Life Sciences Holdings, Inc. (ADLS) Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 8/28/2007
More...
|
Biomira Inc. (BIOM) initiates Phase 1 Trial of PX-478 in Patients with Advanced Metastatic Cancers 8/28/2007
More...
|
Genentech, Inc. (DNA) Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer 8/24/2007
More...
|
Weizmann Institute of Science Scientists Discover a Control Mechanism for Metastasis 8/8/2007
More...
|
University of Pittsburgh Scientists Find New Contributor to Aggressive Cancers 6/6/2007
More...
|
Provectus Pharmaceuticals Inc. Receives Orphan Drug Designation From FDA For Anti-Cancer Agent PV-10 For The Treatment Of Metastatic Melanoma 1/8/2007
More...
|
Vical Incorporated (VICL) Initiates Pivotal Phase 3 Trial Of Allovectin-7(R) As First-line Therapy For Metastatic Melanoma 1/4/2007
More...
|
Nuvelo, Inc. (NUVO) Initiates Phase 2 Trial Of rNAPc2 In Patients With Metastatic Colorectal Cancer 1/4/2007
More...
|
Medarex, Inc. (MEDX) Announces Enrollment Complete In Ipilimumab (MDX-010) Monotherapy Pivotal Registrational Trial For Metastatic Melanoma 1/4/2007
More...
|
Pharmacyclics, Inc. (PCYC) Submits New Drug Application For Xcytrin For The Treatment Of Lung Cancer Brain Metastases 12/22/2006
More...
|
New Genetic Test Predicts Risk Of Metastasis In Patients With Deadly Eye Cancer 11/15/2006
More...
|
Drug Used For Advanced Cancer Could Cause Exposed Bone In Jaw 10/3/2006
More...
|
Core Needle Biopsy Gives An Accurate Picture Of Gene Expression In Whole Tumor 8/18/2006
More...
|
3D Model Reveals Secrets Of Metastasis 7/12/2006
More...
|
Mouse Model Aids Discovery Of Novel Melanoma Metastasis Gene 6/29/2006
More...
|
Data Safety Monitoring Board Recommends Continuation Of ADVENTRX Pharmaceuticals Inc. (ANX) Phase IIb Clinical Trial For CoFactor 6/26/2006
More...
|
CuraGen Corporation (CRGN) Initiates Phase I Clinical Trial With CR011-vcMMAE For Metastatic Melanoma 6/22/2006
More...
|
Research Reveals Secrets Of Cancer's Spread 1/12/2006
More...
|
Vical Incorporated (VICL) Begins Phase 1 Trial Of Gene-Based IL-2 With Inovio Biomedical Corporation (INO) Electroporation Technology 7/18/2005
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Tarceva Granted Approval In Canada For The Treatment Of Advanced Non-Small Cell Lung Cancer 7/14/2005
More...
|
Point Therapeutics Initiates Phase 2 Clinical Trial Of Talabostat In Advanced Pancreatic Cancer 6/23/2005
More...
|
Patient Treatment Initiated In ADVENTRX Pharmaceuticals Inc. (ANX) International Phase IIb Metastatic Colorectal Cancer Trial 5/31/2005
More...
|
Discovery At UCSB May Lead To New Drugs To Treat Cancer, Control Fertility 5/20/2005
More...
|
Amgen (AMGN) Release: Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity In Patients With Metastatic Colorectal Cancer 5/17/2005
More...
|
Regeneron Pharmaceuticals, Inc.'s (REGN) VEGF Trap Demonstrates Positive Preliminary Results From Single-Agent Phase 1 Trial In Patients With Advanced Cancer; Results Presented At American Society of Clinical Oncology Annual Meeting On May 16, 2005 5/17/2005
More...
|
ZymoGenetics (ZGEN) Interleukin 21 Phase 1 Data Presented At American Society of Clinical Oncology Annual Cancer Meeting; Interim Results Show Potential To Treat Metastatic Melanoma And Renal Cell Carcinoma 5/16/2005
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Initiate Phase III Metastatic Melanoma Trial Studying Sorafenib (BAY 43-9006) In Combination With Two Chemotherapeutic Agents 5/13/2005
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Receives ''Compassionate Use'' IND For Use Of DAVANAT/5-FU With A Patient Who Has Cholangiocarcinoma With Liver Metastases 5/12/2005
More...
|
Berlex Inc. Release: Further Trial Data Awaited For Bonefos(R) (NDA) In The U.S.; Stocks Drop 5/11/2005
More...
|
Amgen (AMGN) And Abgenix (ABGX) Release: Phase 3 Clinical Trial Initiated To Evaluate The Use Of Panitumumab Therapy For First-Line Treatment Of Metastatic Colorectal Cancer; Study Evaluates Panitumumab Administered With Bevacizumab And Chemotherapy 4/27/2005
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Receives FDA Clearance For CoFactor Phase III Pivotal Trial In Metastatic Colorectal Cancer 4/25/2005
More...
|
Method Holds Promise In Identifying Markers Of Non-Metastatic Vs. Metastatic Breast Cancer 4/22/2005
More...
|
Medarex, Inc. (MEDX) And Bristol-Myers Squibb Company (BMY) Release: Phase II Clinical Study Of MDX-010/MDX-1379 Combination Shows Durable Responses In Patients With Metastatic Melanoma 4/21/2005
More...
|
GenVec Inc. (GNVC) Reports Preclinical Research At American Association for Cancer Research Showing TNFerade Effective Against Metastases In Melanoma Model And Demonstrating Targeting In Ovarian Cancer Model 4/20/2005
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Presents CoFactor Toxicity And Pharmacodynamics Data Fom Phase II Trial 4/19/2005
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Granted Clearance In The UK For CoFactor Phase IIb Metastatic Colorectal Cancer Trial 4/15/2005
More...
|
ADVENTRX Pharmaceuticals Inc.'s (ANX) CoFactor Phase II And Preclinical Toxicity Data To Be Presented At American Association for Cancer Research Annual Meeting 4/11/2005
More...
|
Advanced Viral Research Corp. (ADVR) Initiates A Phase II, Multi-Center Clinical Trial In The U.S. For AVR118 3/14/2005
More...
|
Celgene Corporation (CELG) Release: REVLIMID(R) Pivotal Phase III Multiple Myeloma Trials Both Exceed Pre-Specified Interim Efficacy Endpoint 3/7/2005
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Announces Promising Findings From Novel Antibody-Chemotherapeutic MLN2704 Prostate Cancer Clinical Trial 2/21/2005
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Approval For U.K. Clinical Trial Investigating REOLYSIN(R) In Combination With Radiation Therapy 2/18/2005
More...
|
Point Therapeutics Announces Positive Phase 2 Interim Results In Single-Agent Talabostat Metastatic Melanoma Study 2/15/2005
More...
|
FDA Agrees To File Abbott Laboratories' (ABT) New Drug Application For Xinlay(TM) (Atrasentan) To Treat Metastatic Hormone-Refractory Prostate Cancer 2/14/2005
More...
|
Advanced Magnetics' (AVM) Combidex(R) To Be Reviewed By FDA Oncologic Drugs Advisory Committee 2/1/2005
More...
|
WorldCare Clinical, Inc. Plays Major Role In Central Image Management For ABRAXANE, A New Class Of Protein Bound Particle Chemotherapy For Metastatic Breast Cancer 1/31/2005
More...
|
OSI Pharmaceuticals, Inc., (OSIP) Genentech, Inc., (DNA) And Roche (RHHBY) Release: Data From Phase III Study Show Tarceva Plus Gemcitabine Significantly Improves Survival Compared to Gemcitabine Alone In Advanced Pancreatic Cancer Patients 1/27/2005
More...
|
Endpoints Met in First Stage Of ADVENTRX Pharmaceuticals Inc. (ANX) CoFactor Phase II Metastatic Colorectal Cancer Study; Patient Enrollment Completed In Phase II Study 1/25/2005
More...
|
CancerVax Corporation (CNVX) To Webcast Corporate Presentation At Piper Jaffray 17th Annual Healthcare Conference 1/20/2005
More...
|
Adherex Technologies Inc. (ARXTF.PK) Initiates Phase Ib/II Exherin(TM) Trial In Europe 1/18/2005
More...
|
Sanofi-Aventis (France) (SASY.PA) Release: Taxotere(R) (Docetaxel) Receives 2 New European Approvals For Treatment Of Breast Cancer 1/11/2005
More...
|
American Pharmaceutical Partners (APPX) Release: FDA Approves ABRAXANE(TM), First In New Class Of Protein-Bound Particle Drugs, For Metastatic Breast Cancer 1/10/2005
More...
|
Diatos S.A. Moves Its Lead Drug, DTS-201, Toward Clinical Trials In Europe 12/16/2004
More...
|
GTx, Inc. (GTXI) Acquires Exclusive Rights In The U.S. For Toremifene In All Indications 12/14/2004
More...
|
Bristol-Myers Squibb Company (BMY) And Medarex, Inc. (MEDX) Provide Additional Information To Federal Trade Commission 12/10/2004
More...
|
Introgen Therapeutics, Inc. (INGN) Release: Addition Of ADVEXIN(R) To Chemotherapy Shows Promise In Treating Locally Advanced Breast Cancer; Stocks Up 12/9/2004
More...
|
Serono International S.A. (SRA) And Micromet To Collaborate In Development And Commercialization Of Novel Anti-Cancer Drug 12/7/2004
More...
|
Advanced Viral Research Corp. (ADVR) Submits An Investigational New Drug -IND- Application For AVR118 11/29/2004
More...
|
Threshold Pharmaceuticals, Inc. Receives FDA Fast-Track Status For Glufosfamide 11/15/2004
More...
|
Bristol-Myers Squibb Company (BMY) And Medarex, Inc. (MEDX) Form Global Development And Commercialization Collaboration For MDX-010 11/8/2004
More...
|
Sanofi-Aventis (France) (SASY.PA) Release: European Union Approval For Taxotere(R) (docetaxel) In Prostate Cancer 11/4/2004
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Release: FDA Clears CoFactor To Begin Second Stage Of Phase II Clinical Trial For Metastatic Colorectal Cancer 11/2/2004
More...
|
Maxim Pharmaceuticals, Inc. (MAXM) To Close Treatment Protocol And Withdraw NDA For Advanced Malignant Melanoma 11/1/2004
More...
|
Amgen (AMGN) And Abgenix (ABGX) Release: Interim Phase 2 Data Suggest Activity Of Panitumumab With Chemotherapy In First-Line Treatment Of Metastatic Colorectal Cancer 11/1/2004
More...
|
Celgene (CELG) Receives FDA Approvable Letter For Thalomid sNDA 10/25/2004
More...
|
Curis, Inc. (CRIS) Release: Hedgehog Pathway Linked To Advanced Stages Of Prostate Cancer 10/20/2004
More...
|
Maxim Pharmaceuticals (MAXM) Announces Restructuring Plan To Support Commercialization And Development Efforts; A Workforce Reduction Of Approximately 50% 10/19/2004
More...
|
CancerVax Corporation (CNVX) To Webcast Corporate Presentation At Rodman & Renshaw Techvest 6th Annual Healthcare Conference 10/14/2004
More...
|
American Pharmaceutical Partners (APPX) Receives FDA Approval For Flumazenil Injection 10/13/2004
More...
|
Aventis S.A. (AVE) Release: Two Landmark Taxotere(R) Studies Featured In The New England Journal of Medicine 10/7/2004
More...
|
CancerVax Corporation (CNVX) To Webcast Corporate Presentation At Biotechnology Industry Organization (BIO) Emerging Company Investor Forum 10/7/2004
More...
|
MethylGene Initiates MG98 Phase II Trial In Metastatic Renal Cell Cancer 10/6/2004
More...
|
Medarex, Inc. (MEDX) Receives FDA Fast Track Designation For MDX-010 Treatment Of Metastatic Melanoma 10/5/2004
More...
|
Proxima Therapeutics Release: First Data On GliaSite Radiation Therapy System As Primary Treatment For Metastatic Brain Cancer Presented At Radiation Oncology Meeting 10/4/2004
More...
|
CancerVax Corporation (CNVX) To Webcast Corporate Presentation At UBS Global Life Sciences Conference 9/23/2004
More...
|
Maxim Pharmaceuticals (MAXM) Phase 3 Trial For Advanced Malignant Melanoma Fails To Meet Primary Endpoint; Stock Falls 9/20/2004
More...
|
Threshold Pharmaceuticals, Inc. Begins Enrollment In Phase 3 Pancreatic Cancer Clinical Trial For Glufosfamide 9/13/2004
More...
|
Schering AG (SHR) Release: Bonefos(R) Accepted For Filing And Granted Priority Review By FDA 9/9/2004
More...
|
Medarex, Inc. (MEDX) Announces Special Protocol Assessment Agreement With FDA To Initiate Phase III Clinical Trial For MDX-010 In Metastatic Melanoma 8/23/2004
More...
|
Wyeth (WYE) Release: FDA Grants Fast Track Status To Temsirolimus, An Investigational Drug For First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma 8/17/2004
More...
|
Positive Clinical Results Observed In Lorus Therapeutics Inc.'s (LORFF) Clinical Trial Of GTI-2040 8/13/2004
More...
|
NeoRx Corporation (NERX) Files IND For STR To Treat Metastatic Breast Cancer 7/6/2004
More...
|
ImClone Systems Incorporated (IMCL) Issues Statement Regarding European Commission Approval For ERBITUX-TM- For The Treatment Of Metastatic Colorectal Cancer 6/30/2004
More...
|
Point Therapeutics Initiates Phase 2 Clinical Trial Studying The Anti-Tumor Activity Of Talabostat - PT-100 - As A Single-Agent In Advanced Metastatic Melanoma 6/30/2004
More...
|
New Insight Into Cancer Metastasis 6/28/2004
More...
|
Protein Stops Blood-Vessel Growth, Holds Promise 6/18/2004
More...
|
Point Therapeutics Initiates Phase 2 Clinical Trial Of Talabostat, PT-100, In Advanced Metastatic Melanoma 6/17/2004
More...
|
ILEX Oncology (ILXO) Initiates ILX-651 Study In Prostate Cancer; Third Phase II Trial In Solid Tumors Now Underway 6/17/2004
More...
|
Veterans Affairs Medical Center And Agennix Release Lactoferrin Cancer Trial Results At ASCO 6/9/2004
More...
|
Celgene Corporation (CELG) Release: Clinical Study Presented On THALOMID(R) Plus Temozolomide Oral Regimen As Adjuvant Therapy For Treating Patients With High Risk Advanced-Stage Metastatic Melanoma 6/8/2004
More...
|
Allos Therapeutics, Inc. (ALTH) Files Application For European Marketing Approval Of RSR13 (efaproxiral) 6/4/2004
More...
|
Maxim Pharmaceuticals (MAXM) Reports Publication Of 36-Month Malignant Melanoma Survival Data For Ceplene 6/4/2004
More...
|
Xanthus Life Sciences Commences Phase I/II Clinical Trial For Xanafide Amonafide In Patients With Prostate Cancer 5/25/2004
More...
|
FDA Grants Approval For Eli Lilly and Company's (LLY) Gemzar(R) In Combination With Taxol(R) As First-line Treatment For Metastatic Breast Cancer 5/20/2004
More...
|
OXiGENE (OXGN) Release: Principal Investigator Reports Positive Interim Data On Phase Ib/II Trial Of OXiGENE's CA4P In Advanced Ovarian Cancer 5/19/2004
More...
|
American Pharmaceutical Partners (APPX) And American BioScience, Inc. Announce FDA Acceptance Of New Drug Application Of ABRAXANE(TM) For The Treatment Of Metastatic Breast Cancer 5/10/2004
More...
|
Oxford BioMedica PLC (LS:OXB) Gains FDA Approval For A Phase II Trial Of Trovax® In Renal Cancer 4/29/2004
More...
|
Unlikely Protein Boosts Metastatic Colon Cancer Growth 4/23/2004
More...
|
MedImmune (MEDI) And Cerus Corporation (CERS) Enter Agreement To Co-Develop Therapeutic Vaccine For Cancer 4/21/2004
More...
|
Stem Cells Help Attack Cancer In Mice 3/30/2004
More...
|
Dendreon Corporation's (DNDN) APC8024 Immunotherapy Shows Long-Term Disease Stabilization And Significant Immune Response In Advanced, Metastatic Breast Cancer Patients 3/29/2004
More...
|
New Findings Presented At American Association For Cancer Research Show Ligand Pharmaceuticals Inc.'s (LGND) Targretin Synergizes With Chemotherapeutic Agents To Arrest NSCLC Growth and Prevents or Reverses Acquired Paclitaxel And Taxol Resistance In NSCLC And Advanced Breast Cancer 3/29/2004
More...
|
Merck KGaA (DE:FMRK): Imminent EU Approval For Erbitux Provides New Hope For Colorectal Cancer Patients 3/25/2004
More...
|
ImClone Systems Incorporated (IMCL) Issues Statement Regarding Recommendation By Committee For Proprietary Medicinal Products To Approve ERBITUX-TM- In Europe 3/25/2004
More...
|
Researchers Model Embryo Implantation And Tumour Metastasis In Fruit Flies 3/12/2004
More...
|
Celgene Corporation's (CELG) REVLIMID(TM) Receives Orphan Drug Designation From The European Commission For Myelodysplastic Syndromes 3/3/2004
More...
|
Allos Therapeutics, Inc. (ALTH) Begins Phase 3 Study Of RSR13 In Women With Brain Metastases From Breast Cancer 2/12/2004
More...
|
Allos Therapeutics, Inc. (ALTH) Reports Fourth Quarter And Year-End 2003 Results 2/12/2004
More...
|
Immunomedics, Inc. (IMMU) Reports Phase II Colorectal Cancer Therapy Data At GI Cancer Symposium 1/26/2004
More...
|
Dendreon Corporation's (DNDN) Provenge Extends Survival In Advanced Prostate Cancer By Over Eight Months In Patients With Gleason Scores Of Seven And Less; Stock Soars 1/12/2004
More...
|
Genta Incorporated (GNTA) Completes New Drug Application For Approval Of Genasense(TM) In Patients With Advanced Malignant Melanoma 12/9/2003
More...
|
Light Sciences Actively Enrolling In Phase II Clinical Trial Of Litx(TM) For Liver Metastases 12/3/2003
More...
|
Pharmacyclics (PCYC) Receives FDA Fast Track Status For Xcytrin 12/2/2003
More...
|
Telik, Inc. (TELK) Announces FDA Fast Track Designation For TELCYTA(TM) For Non-Small Cell Lung Cancer 12/2/2003
More...
|
ImClone (IMCL) Issues Statement Regarding Swissmedic Approval For ERBITUX For The Treatment Of Advanced Metastatic Colorectal Cancer 12/1/2003
More...
|
Genentech (DNA) Announces FDA Acceptance Of Biologics License Application With Priority Review Of Avastin In First-Line Metastatic Colorectal Cancer 12/1/2003
More...
|
Genentech (DNA) Reports Results From Phase II Trial Of Avastin In Metastatic Colorectal Cancer; Drug Fails Trial 11/26/2003
More...
|
Allos Therapeutics, Inc. (ALTH) Announces RSR13 Phase 3 Results In Patients With Breast Cancer And Brain Metastases Will Be Highlighted At The 26th Annual San Antonio Breast Cancer Symposium 11/24/2003
More...
|
ImClone (IMCL) And Bristol-Myers Squibb Company (BMY) File New Drug Submission With Health Canada For Use Of ERBITUX--Cetuximab--For Treatment Of EGFR-Expressing Irinotecan-Refractory Metastatic Colorectal Cancer 11/24/2003
More...
|
Anti-platelet Drug Blocks Bone Metastases In Mice; Treatment Also Slows Development Of Other Tumors 11/4/2003
More...
|